Curcumin also inhibits the constitutive activation of pro-survival pathways, some of which are preferentially active in primary B-cell chronic lymphocytic leukaemia (B-CLL) cells, including STAT3, Akt, and NF-κB [63,64]. This evidence concerns the gene STAT3 and B-cell chronic lymphocytic leukemia.